Follow Slashdot stories on Twitter

 



Forgot your password?
typodupeerror
×
Medicine Businesses

City Sues Drug Manufacturer Mallinckrodt Over 97,500% Price Increase (wsbtv.com) 206

McGruber quotes Atlanta TV station WSB: The city of Marietta, Georgia is suing drug manufacturer Mallinckrodt after Mallinckrodt increased the price of the drug Acthar by 97,500%.

The lawsuit, filed in federal court, claims one city employee needs the drug Acthar, which is used to treat seizures in small children.

"Acthar used to cost $40, but Mallinckrodt has raised the price of the drug to over $39,000 per vial," the city claims in the lawsuit. "This eye-popping 97,500% price increase is the result of unlawful and unfair conduct by Mallinckrondt. The city has expended over $2 million for just one patient covered by the city's self-funded health plan...."

Atlanta pharmacist Ira Katz said Acthar is what's called a "biologic" and they can be classified as specialty drugs. "They put them into the specialty class, and the prices are outrageous, just outrageous," Katz said.

This discussion has been archived. No new comments can be posted.

City Sues Drug Manufacturer Mallinckrodt Over 97,500% Price Increase

Comments Filter:
  • I know this is beside the point, but it just seemed like a huge mistake waiting to happen. Too small for any negotiating power and too small of a group to afford rare but expensive events. Who in their right mind would try to self-fund something so variable with a group so small?

    • by Tim Hamilton ( 5961502 ) on Saturday February 22, 2020 @05:45PM (#59755184)
      I'm not sure how that would change the price of the drug when one company run by psychotics has the monopoly. And this is usually how it goes. They have a FDA-granted monopoly or a de facto court-granted monopoly. The red tape is meant to stop anyone from competing, patent or not.
      • It wouldn't change the price, but it would manage the cost by spreading it out over a bigger random distribution of people. That's why I admitted it was off topic at the start of my post.

        Still, a larger insurance company can negotiate better prices than retail because refusing to cover it at all would be a big loss to the drug company.

        • It wouldn't change the price, but it would manage the cost by spreading it out over a bigger random distribution of people.

          Actually, that would change the price. If the price could be spread out enough that no single individual cares enough to protest, the price can be jacked up even more.

          • Individuals don't (typically) pay more or less for any covered drug. (Sometimes there's a copay discount for generics, but that's from the insurer, not the manufacturer.) So if the insurer has 1000 patients that need drug X, they can tell the manufacturer "we won't pay more than $40," and the vendor can either lose $40x1000 per month in sales (or week, or perhaps even day), or else they can sell it at whatever price they end up negotiating on.

            Note that these negotiated prices applies ONLY that ONE insurer

      • Clearly you need a company run by antipsychotics to counter the company.run by psychotics.
      • by kenh ( 9056 )

        Remove patent protection, and Drug companies will stop risking hundreds of millions of dollars to develop a new drug. Why innovate, when you can just take someone else's formula and undercut their price since you don't have to recover your investment?

        I would have liked to know how many other people suffer with this ailment and are on this medication.

        I'd also like to know why this town self-insures, yet apparently doesn't have catastrophic coverage for just such an event.

        I suspect the right price for the dru

    • by sjames ( 1099 )

      Re-insurance covers much of that and is probably a lot cheaper than outsourcing insurance.

    • Actually, I think that we need to encourage these insurance companies to do their own drug companies. In nearly all cases, generics and biologics are dirt cheap. Even with the generics, they are much cheaper than what the insurances are paying in America.
    • by Cylix ( 55374 )

      Lots of organizations self fund and depending on the size of the org it can be a cost benefit. In many cases, self funding is somewhat hidden from the employee, the company in question uses a typical medical insurance company to handle the books and other management tasks.

      That is a fairly standard practice for organizations and this is clearly an abuse of obtaining a special category. Long term, similar cases have yielded negative results for companies which practice these outrageous pricing schemes.

  • Not sure about (Score:4, Interesting)

    by oldgraybeard ( 2939809 ) on Saturday February 22, 2020 @05:49PM (#59755200)
    Municipalities, I agree about group size. So why are small business BANNED by health regulations from joining together to buy health care.

    The local chamber of commerce members can not join together and bargain for healthcare. It is the Government involvement and the regulations purchased from the government by the healthcare industry that make our system so expensive.

    Just my 2 cents ;)
    • by rsilvergun ( 571051 ) on Saturday February 22, 2020 @08:18PM (#59755568)
      a bunch of small business owners banding together wouldn't be able to effectively bargain against a large pharmaceutical company. I suppose if every single business owner got together nationally, but at that point why not just do Medicare for All? It's been shown to work in every country on earth and Medicare has virtually no red tape, it's got much, much lower overhead than private health insurance.
      • by kenh ( 9056 )

        Medicare has virtually no red tape, it's got much, much lower overhead than private health insurance.

        It's got a fair bit of "waste, fraud, and abuse" - 10% of medicare budget is wasted [slashdot.org].

        Medicare off-loads a lot of it's overhead onto the social security system, which gives you an unrealistically-low overhead ratio. Yes, Medicare costs less to administer, unless you include the 10% waste that is the result of it's minimal oversight.

  • Somewhat unusually, the drug is only available in the US, so the usual cost comparison with e.g. UK NHS is not possible.

    • http://www.epilepsyaustralia.n... [epilepsyaustralia.net]

      Adrenocorticotropic Hormone Acthar, Synacthen

      Its available in Australia

  • by Futurepower(R) ( 558542 ) on Saturday February 22, 2020 @06:00PM (#59755228) Homepage
    In debates of Democratic candidates for president, several of the candidates have said that the medical system in the U.S. needs thorough revision.

    I agree with that. One of the many, many problems: Drugs in the U.S. are allowed to have more than one name!!! See Overview of Generic Drugs and Drug Naming. [merckmanuals.com]

    Another article: Multiple Brand Names for the Same Generic Drug Can Cause Confusion. [nih.gov]
  • Comment removed (Score:5, Insightful)

    by account_deleted ( 4530225 ) on Saturday February 22, 2020 @06:00PM (#59755230)
    Comment removed based on user account deletion
    • by sgage ( 109086 )

      Nothing will change until - AND I DON'T ADVOCATE THIS! - big rapacious pharma corporations start seeing their execs being wacked. It's bound to happen sooner or later. Some guy knows there's a medicine that will save his daughter's life, but now it's tens of thousands of dollars a month. It was $40 last month. He snaps. It's gonna happen, sooner or later.

      • I advocate it. Executives responsible for things like this should be dragged from their homes and offices and executed publicly.

        The tree of liberty must be refreshed from time to time with the blood of patriots and tyrants.

        At one point we had laws specifically prohibiting price gouging, and we required corporations to operate for the public benefit. Note that "for the public benefit" is not the same as "not-for-profit".

      • That'll just make things worse. The fundamental problem here is that there aren't enough pharmaceutical companies making generic drugs (Mallinckrodt can only jack up the price this much if nobody else is making it). Scaring off companies making generic drugs will just exacerbate the situation. The end state if we go down that route is that these generic drugs won't be available at any price because nobody wants to take the risk of being whacked by some idiot who decides on his own that pharama company exec
      • and then the General. And give him a left leaning Congress to pass Medicare for All. No more bullshit half measures, insurance works best with a big pool of the insured, and there's no bigger pool than "everybody". And you still get choice, you get more choice since you can pick any doctor instead of the ones in network. Hell, it's not like you have any choice now, your job can change your insurance on a whim.
        • by kenh ( 9056 )

          And you still get choice, you get more choice since you can pick any doctor instead of the ones in network.

          I'll let you in on a little secret - the only reason doctors, hospitals accept Medicare reimbursements which are frequently below the cost of providing the care/service, is because of the existence of private insurance which generally reimburses at levels above the cost of providing the care/service.

          More than two-thirds (67%) of medical practices report that 2019 Medicare payments will not cover the cost of delivering care to beneficiaries according to a new MGMA Stat poll. Practices often rely on commercial contracts covering non-Medicare patients to offset the shortfall.

          Source: Medicare reimbursement falls short of care delivery costs [mgma.com]

          Question, what happens when non-medicare providers exit the market and we have "medicare for all"? How long will your local hospital stay open whe

      • Those CEO's would not want me on the jury of the person who wacked them. Can you say jury nullification.
    • by KixWooder ( 5232441 ) on Saturday February 22, 2020 @06:25PM (#59755304)
      Acthar is off-patent and has been since the 60s.
      • under one of the "abandoned" drug rules? I know they've done that with other drugs. Most countries just manufacture the drugs themselves, but we don't do that in America. Instead we grant a monopoly to a single company and, well, they charge 100,000 times as much since without it you die.
    • by hwihyw ( 4763935 )

      Lot of these drugs as off patent. A patent has a duration of 17 years, hence, such "simple drugs from 1933" are off patent. Same with Epipen, Acthar, etc.

      So what is the issue then? I'm tired of explaining it to people, so go to Walmart and see what the drugs off the shelf cost. Go to your pharmacy and see what prescription drugs cost. Keep in mind there are many new drugs at Walmart that are patented, and many prescription drugs at the pharmacy that are off patent (Epipen, Acthar, etc).

      • One of the issues is that there are many, many drugs that have been in common use for decades, but haven't been subjected to the exhaustive FDA testing/approval process. One such drug was colchicine, which had been in use for literally hundreds of years for treating acute symptoms of gout. The FDA started a program several years ago to offer a monopoly (but not a patent) on these older drugs to companies that would undertake the desired testing. The result in the case of colchicine was that a company cal

    • they're going after drugs that affect relatively or very few people, most people don't need much medical care until their mid 60s besides pre/post natal (which totals around $20-$30k out of pocket 2 or 3 times in your life). It's not hard to use arguments like "choice" to keep folks from regulating or eliminating private health insurance systems that promote this behavior under those circumstances. If they did it with one of the major Statin heart medicines maybe, but for this stuff it's perfectly doable.
  • Mallinckrodt (Score:4, Insightful)

    by fred911 ( 83970 ) on Saturday February 22, 2020 @06:58PM (#59755390) Journal

    Has a great reputation. From 2006-1012 their subsidy SpecGx supplied 28.9 billion oxycodone pills to the market. Worst than any drug dealer. Not to mention their tax avoidance history.

    https://en.wikipedia.org/wiki/... [wikipedia.org]

  • I understand it used to be that way and I think it should go back to being that way.
    • by kenh ( 9056 )

      I don't think the pharma industry was ever "not for profit" - I'd appreciate a citation for your assertion.

  • I understand that drug manufacturers want to make money. They are private companies, and making money is their duty.

    However, these ridiculous price hikes are not the right way to do it.
    Martin Shkreli did that, and he ended up in jail as one of the most hated men on the planet, and his company lost money. You can be aggressive, but being a complete asshole almost never pays in the end. You may see short term profits but after that, no one will want to do business with you.

    BTW, aren't some labs able to produc

  • Acthar is a brand of adenocorticotropic hormone (ACTH), a compound which has been researched since WW II. Since ACTH has been on the market since 1952, it is now long since off patent. For more reasonable world prices, shop here:
    https://www.mybiosource.com/ac... [mybiosource.com]

    I'm assuming it's probably Chinese, but so be it. I hope China steals all our pharma patents, cranks up production to 11 and sends our domestic monopoly straight to the perdition it deserves. Then we can shop the world market and be treated at open-m

    • by kenh ( 9056 )

      I hope China steals all our pharma patents, cranks up production to 11 and sends our domestic monopoly straight to the perdition it deserves. Then we can shop the world market and be treated at open-market prices once more.

      And we'll never see a new drug or treatment again.

      Reminds me of the time the Russians killed all the farmers and took their land, only to watch millions of Russians die of starvation.

      Or when Venezuela nationalized the oil fields and took over oil production, only to kill their main source of revenue and casting the nation into abject poverty and mass starvation.

      Sure, sounds like a great idea, kill of any possibility of new treatments ever again in exchange for cheaper (if unsafe) chinese prescriptions - wha

  • Seriously, we need to change the patent laws to say that if a drug is not a cure, then it should only have a 5 year life time.
    And if it is a cure (i.e. single treatment as opposed to recurring treatments), then give it 10 years.

    Finally, we need to stop ads for medicines that require a doctor's treatments. The idea of targeting ppl with drugs that only a doctor can prescribe is just wrong. Far too much money is spent on pushing these. In fact, most drugs companies spend many times more money on Ads than

Keep up the good work! But please don't ask me to help.

Working...